A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/29/2002	US6472145 A mobile ionophore composition effective to modulate app catabolism without substantially altering the viability of app-containing cells; inhibits amyloid deposition; alzheimer's disease; nontoxic
10/29/2002	US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002	US6471998 Chromium picolinate compositions
10/29/2002	US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/29/2002	US6471979 Applying formulation comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (serm) to stent; inserting stent for releasing formulation
10/29/2002	US6471978 Localized use of nitric oxide-adducts to prevent internal tissue damage
10/29/2002	US6471973 Drugs, cosmetics, dietetics, agriculture
10/29/2002	US6471972 Cosmetic treatment method for fighting against skin ageing effects
10/29/2002	US6471969 Two-phase preparation
10/29/2002	US6471968 Multifunctional nanodevice platform
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	US6471955 Polystyrenes as preferential time-release agents or carriers of prostaglandins such as misoprostol used for prevention of peptic ulcers
10/29/2002	US6471954 Water-soluble glycerine and plant extracts, oil soluble emulsifiers, squalane and avocado oil are separately and inter mixed under pressure, further adding alpha-tocopherol, tocopherol acetate, retinyl palmitate and retinyl acetate;
10/29/2002	US6471946 Oral composition
10/29/2002	US6471943 Formulation and method for treating neoplasms by inhalation
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/29/2002	CA2291068C Method for the preparation of citalopram
10/29/2002	CA2263455C Liposomes containing a cisplatin compound
10/29/2002	CA2236553C Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
10/29/2002	CA2215922C Methods for screening compounds for estrogenic activity
10/29/2002	CA2210492C Neuraminic acid derivatives, their preparation and their medical use
10/29/2002	CA2179988C Pharmaceutical formulations comprising polythiourea and method of use thereof
10/29/2002	CA2156493C Method of preventing or inhibiting fertilization
10/29/2002	CA2138683C Semi-paste oral preparations
10/29/2002	CA2115053C Antimicrobial dialdehyde composition and methods of use
10/29/2002	CA2107471C Fluorine-containing vitamin d3 analogues
10/29/2002	CA2088128C Salts of glucopyranose derivatives and its intermediate
10/29/2002	CA2068231C Process for the preparation of benzothiazepines by cyclization with phosphonic acids
10/29/2002	CA2045552C Cancer related haptoglobin
10/28/2002	WO2001082909A2 2-acyl indol derivatives and their use as anti-tumour agents
10/28/2002	EP1009417A4 Dietary supplements containing natural ingredients
10/28/2002	CA2407677A1 2-acyl indol derivatives and their use as anti-tumour agents
10/26/2002	CA2345816A1 Livestock feedlot adaptation treatment method and product
10/25/2002	EP1194142A4 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate!
10/25/2002	EP1017376A4 Method of treating heart failure
10/25/2002	CA2383175A1 Methods and kits for treating depression or preventing deterioration of cognitive function
10/25/2002	CA2382806A1 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083920A2 Nucleic acid sequences useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083891A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083705A1 Socs-1 gene methylation in cancer
10/24/2002	WO2002083703A1 Composition based on a s-adenosyl-l-methionine polyphosphate and uses of such a polyphosphate
10/24/2002	WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	WO2002083696A2 Novel cyclo azaphospha hydrocarbons
10/24/2002	WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002	WO2002083692A1 Process for the selective preparation of 3-(z) propenyl-cephem compound
10/24/2002	WO2002083689A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
10/24/2002	WO2002083688A1 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
10/24/2002	WO2002083687A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
10/24/2002	WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083683A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083682A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083681A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	WO2002083680A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083679A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083678A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083675A2 Inhibitors of akt activity
10/24/2002	WO2002083674A2 Compositions containing imidazotriazinone for nasal application
10/24/2002	WO2002083673A1 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
10/24/2002	WO2002083672A1 Antiviral pyrazolopyridine compounds
10/24/2002	WO2002083671A1 Mercaptoacetylamide derivatives, a process for their preparation and their use
10/24/2002	WO2002083669A1 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083660A1 Remedies
10/24/2002	WO2002083658A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
10/24/2002	WO2002083657A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/24/2002	WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002	WO2002083655A1 Prodrugs of cox-2 inhibitors
10/24/2002	WO2002083652A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
10/24/2002	WO2002083651A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083644A1 Halogenated quinoline derivatives and ectoparasite controllers
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083640A1 Nicotinic acetylcholine receptor ligands
10/24/2002	WO2002083632A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands

1 ... 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 5687 5688 ... 7860